Key Highlights
- Consensus estimates call for Q1 earnings of $6.05 per share alongside revenue reaching $9.76 billion, representing 3.1% annual growth
- Street maintains Buy rating with average target of $736.24, suggesting approximately 11% potential gain from current ~$665 level
- Primary focus: profitability improvement, with segment operating margins projected to reach roughly 11%
- Latest developments feature a $475M Glide Phase Interceptor contract modification plus inaugural engine test of YFQ-48A Talon Blue unmanned aircraft
- Shares have declined 2% during the past 30 days, trailing the aerospace/defense sector’s 10.3% advance
Northrop Grumman delivers its first quarter 2026 financial results Tuesday morning before market open. Following an extended period of significant development expenditures, the investment community seeks clarity on one critical question: has the anticipated profitability rebound arrived?
Northrop Grumman Corporation, NOC
Analyst projections point to earnings per share of $6.05 with revenue totaling $9.76 billion. While these figures represent a sequential decline from the fourth quarter’s $7.23 EPS and $11.7 billion top line, such patterns are standard within the industry. Defense companies routinely deliver their strongest quarterly performance during the final three months of each year.
Compared to the same period last year, revenue projections indicate 3.1% expansion. This would mark a significant turnaround from the 6.6% contraction NOC experienced during the prior year’s opening quarter.
During the December quarter, Northrop exceeded expectations on both top and bottom lines. The company generated $11.71 billion in revenue, marking 9.6% year-over-year growth. Earnings per share reached $7.23, surpassing the $6.99 Street consensus. However, full-year earnings guidance disappointed investors, coming in below analyst projections.
Shares currently trade in the $665–$667 range, positioned near the midpoint of the 52-week trading band between $450.13 and $774.00. Wall Street price objectives have gradually increased. Wells Fargo launched coverage with a Buy recommendation and $800 target on March 31. Deutsche Bank elevated its price target to $778 on April 8. Jefferies adjusted its Hold-rated objective upward to $710 on April 9.
Earnings per share projections have improved 0.51% during the past two months. Revenue forecasts have risen 0.24%. While these adjustments are modest, the trend remains constructive.
Profitability Improvement Under Scrutiny
The critical issue investors will examine Tuesday centers on whether operational margin expansion is materializing in reported results. Wall Street anticipates segment operating margins recovering to approximately 11%.
The Aeronautics division benefits from cycling past a B-21 Raider development charge recorded in the year-ago period, which should provide support. Mission Systems stands to gain from an improved program composition. Should both divisions meet expectations, it would demonstrate that Northrop’s capital-intensive development phase is transitioning toward improved profitability.
Full-year earnings guidance represents another area of interest. Management’s current outlook spans $27.40 to $27.90 per share. Analysts anticipate the company will maintain that range, though some believe the more compelling growth narrative unfolds in 2027.
Recent Program Developments Set the Stage
Northrop has maintained an active April on the contract announcement front. The defense contractor secured a $475 million contract modification to expedite development of its Glide Phase Interceptor system. The YFQ-48A Talon Blue autonomous combat drone achieved its first engine operation on April 17. Additionally, the Sentinel intercontinental ballistic missile program continues progressing toward an initial flight test scheduled for 2027.
NOC shares have retreated approximately 2% during the trailing month. The broader aerospace and defense industry has advanced 10.3% over the same timeframe, positioning Northrop among the sector’s relative underperformers entering this earnings announcement.
Industry peers have already begun releasing quarterly results. AAR delivered 24.6% revenue expansion while beating estimates, sending its stock 9.9% higher. Byrna achieved 10.9% growth but fell short of expectations, triggering a 38.3% decline.
Analysts have maintained relatively stable estimates throughout the past month, indicating limited anticipation of major positive or negative surprises.
